Yıl: 2023 Cilt: 57 Sayı: 2 Sayfa Aralığı: 272 - 278 Metin Dili: İngilizce DOI: 10.14744/SEMB.2023.48991 İndeks Tarihi: 11-07-2023

Intraoperative Parathyroid Hormone Monitoring-Guided Subtotal Parathyroidectomy is an Effective and Valid Surgical Procedure for Secondary Hyperparathyroidism

Öz:
Objectives: Secondary hyperparathyroidism (sHPT) is a prevalent complication of end stage renal disease in which serious morbid conditions and mortality can be encountered. Although the best solution of this severe problem is renal transplantation, because of the huge demand and limited resources, this cannot be possible most of the time. Initial treatment alternative is medical treat- ment in patients with sHPT and parathyroidectomy (PTX) should be applied if does not help. Subtotal PTX, total PTX and total PTX together with autotransplantation are the current surgical options preferred for sHPT. Intraoperative parathyroid hormone (IO PTH) monitoring can increase surgical success in sHPT. We aimed to determine the ideal surgical technique and relation of IO PTH monitoring with surgical success in patients with sHPT through our study. Methods: We analyzed all the data of the 35 patients who had PTX and follow up between January 2001 and December 2021 be- cause of sHPT at General Surgery Department of Akdeniz University Medical Faculty Hospital in retrospective manner. Results: Twenty-seven of the patients had been applied subtotal PTX while six of the cases had experienced limited surgery and two of them had undergone total PTX. Persistance happened to be present in the follow-up of nine patients and recurrence in one of them. Four persistant and one recurrent cases were present in 23 patients with IO PTH monitoring (78.3% surgical success), while there were persistences in each of the three patients with no IO PTH monitoring (0% success of surgery) (p=0.022). IO PTH monitoring data of nine patients could not be reached. In this study, 20 patients had IO PTH decline of 80% or more (90% surgical success) and three patients had IO PTH decline below 80% (0% surgical success) (p=0.006). Subtotal PTX was applied to 17 (94.1% surgical success) of these 20 patients. Conclusion: In surgical treatment of patients with sHPT, IO PTH monitoring should be maintained and operation should not be finished until 80% or more decline in IO PTH level had been detected. Among the surgical alternatives for sHPT, subtotal PTX ap- pears as an effective and valid method when performed together with IO PTH monitoring, provided that there is a decline in PTH level of 80% or more.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Liu ME, Qiu NC, Zha SL, Du ZP, Wang YF, Wang Q, et al. To assess the effects of parathyroidectomy (TPTX versusTPTX+AT) for Secondary Hyperparathyroidism in chronic renal failure: a systematic review and meta-analysis. Int J Surg 2017;44:353-62. [CrossRef]
  • 2. Trunzo JA, McHenry CR, Schulak JA, Wilhelm SM. Effect of parathyroidectomy on anemia and erythropoietin dosing in end- stage renal disease patients with hyperparathyroidism. Surgery 2008;144:915-8. [CrossRef ]
  • 3. Changjia Li, Liang Lv, Hongqiao Wang, Xufu Wang, Bangxu Yu, Yan Xu, Xiaobin Zhou, et al. Total parathyroidectomy versus total parathyroidectomy with autotransplantation for secondary hyperparathyroidism: systematic review and meta-analysis. Renal Failure 2017;39:678-87. [CrossRef ]
  • 4. Van der Plas W, Kruijff S, Sidhu SB, Delbridge LW, Sywak MS, Engelsman AF. Parathyroidectomy for patients with secondary hyperparathyroidism in a changing landscape for the management of end-stage renal disease. Surgery 2021;169:275-81. [CrossRef]
  • 5. Reese PP, Shults J, Bloom RD, Mussell A, Harhay MN, Abt P, et al. Functional status, time to transplantation, and survival benefit of kidney transplantation among wait-listed candidates. Am J Kidney Dis 2015;66:837-45. [CrossRef ]
  • 6. Tanrıkulu Y, Temiz A, Karadeniz E. Surgical treatment of secondary hyperparathyroidism. Ann Med Res 2019;26:1792-7. [CrossRef ]
  • 7. Uludağ M. Secondary hyperparathyroidism in patients with chronic kidney disease: diagnosis, pharmacological and surgical treatment. Sisli Etfal Hastan Tip Bul [Article in Turkish] 2016;50:256-72. [CrossRef ]
  • 8. National Kidney Foundation. KDOQI clinical practice guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 2003;42 Suppl 3:S1-202. [CrossRef ]
  • 9. Lorenz K, Bartsch DK, Sancho JJ, Guigard S, Triponez S. Surgical management of secondary hyperparathyroidism in chronic kidney disease--a consensus report of the European Society of Endocrine Surgeons. Langenbecks Arch Surg 2015;400:907-27. [CrossRef ]
  • 10. Tominaga Y, Matsuoka S, Uno N. Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis. World J Surg 2009;33:2335-42. [CrossRef ]
  • 11. Shih ML, Duh QY, Hsieh CB, Lin SH, Wu HS, Chu PL, et al. Total parathyroidectomy without autotransplantation for secondary hyperparathyroidism. World J Surg 2009;33:248-54. [CrossRef ]
  • 12. Hou J, Shan H, ZhangY, Deng X, Guo B, Kang J, et al. Network meta- analysis of surgical treatment for secondary hyperparathyroidism. Am J Otolaryngol 2020;41:102370. [CrossRef ]
  • 13. Liang Y, Sun Y, Ren L, Qi XW, Li Y, Zhang F. Short-term efficacy of surgical treatment of secondary hyperparathyroidism. Eur Rev Med Pharmacol Sci 2015;19:3904-9.
  • 14. Soares MR, Cavalcanti GV, Iwakura R, Lucca LJ, Romão EA, Conti de Freitas LC. Analysis of the role of thyroidectomy and thymectomy in the surgical treatment of secondary hyperparathyroidism. Am J Otolaryngol 2019;40:67-9. [CrossRef ]
  • 15. AmzaAB,MunteanV,DindeleganG,CiuceC,GeorgescuCE.Surgery outcomes in patients with secondary hyperparathyroidism and impact of intraoperative pth measurement. Acta Endocrinol (Buchar) 2017;13:322-8. [CrossRef ]
  • 16. ChenHH,LinCJ,WuCJ,LaiCT,LinJ,ChengSP,etal.Chemicalablation of recurrent and persistent secondary hyperparathyroidism after subtotal parathyroidectomy. Ann Surg 2011;253:786-90. [CrossRef]
  • 17. Rothmund M, Wagner PK. Assessment of parathyroid graft function after autotransplantation of fresh and cryopreserved tissue. World J Surg 1984;8:527-33. [CrossRef ]
  • 18. Schlosser K, Zielke A, Rothmund M. Medical and surgical treatment for secondary and tertiary hyperparathyroidism. Scand J Surg 2004;93:288-97. [CrossRef ]
  • 19. Konturek A, Barczyński M, Stopa M, Nowak W. Subtotal parathyroidectomy for secondary renal hyperparathyroidism: a 20-year surgical outcome study. Langenbecks Arch Surg 2016;401:965-74. [CrossRef ]
  • 20. Neagoe RM, Mureșan M, Voidăzan S, Pașcanu I, Radu CP, Sala DT. Subtotal parathyroidectomy versus total parathyroidectomy with autotransplant in secondary hyperparathyroidism - a single-centre prospective cohort of 43 patients. Endokrynol Pol 2016;67:202-9. [CrossRef ]
  • 21. Conzo G, Perna AF, Sinisi AA, Palazzo A, Stanzione F, Della Pietra C, et al. Total parathyroidectomy without autotransplantation in the surgical treatment of secondary hyperparathyroidism of chronic kidney disease. J Endocrinol Invest 2012;35:8-13.
  • 22. Yuan Q, Liao Y, Zhou R, Liu J, Tang J, Wu G. Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation for secondary hyperparathyroidism: an updated systematic review and meta-analysis. Langenbecks Arch Surg 2019;404:669-79. [CrossRef ]
  • 23. Ohe MN, Santos RO, Kunii IS, Carvalho AB, Abrahão M, Neves MC, et al. Intraoperative PTH cutoff definition to predict successful parathyroidectomy in secondary and tertiary hyperparathyroidism. Braz J Otorhinolaryngol 2013;79:494-9. [CrossRef ]
  • 24. Pitt SC, Panneerselvan R, Chen H, Sippel RS. Secondary and tertiary hyperparathyroidism: the utility of ioPTH monitoring. World J Surg 2010;34:1343-9. [CrossRef ]
APA GUZEL G, Sarıdemir Ünal D, ÖZEN A, aydemir m, Çalış H, Boz A, Arıcı C (2023). Intraoperative Parathyroid Hormone Monitoring-Guided Subtotal Parathyroidectomy is an Effective and Valid Surgical Procedure for Secondary Hyperparathyroidism. , 272 - 278. 10.14744/SEMB.2023.48991
Chicago GUZEL GOKMEN,Sarıdemir Ünal Demet,ÖZEN ANIL,aydemir mustafa,Çalış Hasan,Boz Adil,Arıcı Cumhur Intraoperative Parathyroid Hormone Monitoring-Guided Subtotal Parathyroidectomy is an Effective and Valid Surgical Procedure for Secondary Hyperparathyroidism. (2023): 272 - 278. 10.14744/SEMB.2023.48991
MLA GUZEL GOKMEN,Sarıdemir Ünal Demet,ÖZEN ANIL,aydemir mustafa,Çalış Hasan,Boz Adil,Arıcı Cumhur Intraoperative Parathyroid Hormone Monitoring-Guided Subtotal Parathyroidectomy is an Effective and Valid Surgical Procedure for Secondary Hyperparathyroidism. , 2023, ss.272 - 278. 10.14744/SEMB.2023.48991
AMA GUZEL G,Sarıdemir Ünal D,ÖZEN A,aydemir m,Çalış H,Boz A,Arıcı C Intraoperative Parathyroid Hormone Monitoring-Guided Subtotal Parathyroidectomy is an Effective and Valid Surgical Procedure for Secondary Hyperparathyroidism. . 2023; 272 - 278. 10.14744/SEMB.2023.48991
Vancouver GUZEL G,Sarıdemir Ünal D,ÖZEN A,aydemir m,Çalış H,Boz A,Arıcı C Intraoperative Parathyroid Hormone Monitoring-Guided Subtotal Parathyroidectomy is an Effective and Valid Surgical Procedure for Secondary Hyperparathyroidism. . 2023; 272 - 278. 10.14744/SEMB.2023.48991
IEEE GUZEL G,Sarıdemir Ünal D,ÖZEN A,aydemir m,Çalış H,Boz A,Arıcı C "Intraoperative Parathyroid Hormone Monitoring-Guided Subtotal Parathyroidectomy is an Effective and Valid Surgical Procedure for Secondary Hyperparathyroidism." , ss.272 - 278, 2023. 10.14744/SEMB.2023.48991
ISNAD GUZEL, GOKMEN vd. "Intraoperative Parathyroid Hormone Monitoring-Guided Subtotal Parathyroidectomy is an Effective and Valid Surgical Procedure for Secondary Hyperparathyroidism". (2023), 272-278. https://doi.org/10.14744/SEMB.2023.48991
APA GUZEL G, Sarıdemir Ünal D, ÖZEN A, aydemir m, Çalış H, Boz A, Arıcı C (2023). Intraoperative Parathyroid Hormone Monitoring-Guided Subtotal Parathyroidectomy is an Effective and Valid Surgical Procedure for Secondary Hyperparathyroidism. Şişli Etfal Hastanesi Tıp Bülteni, 57(2), 272 - 278. 10.14744/SEMB.2023.48991
Chicago GUZEL GOKMEN,Sarıdemir Ünal Demet,ÖZEN ANIL,aydemir mustafa,Çalış Hasan,Boz Adil,Arıcı Cumhur Intraoperative Parathyroid Hormone Monitoring-Guided Subtotal Parathyroidectomy is an Effective and Valid Surgical Procedure for Secondary Hyperparathyroidism. Şişli Etfal Hastanesi Tıp Bülteni 57, no.2 (2023): 272 - 278. 10.14744/SEMB.2023.48991
MLA GUZEL GOKMEN,Sarıdemir Ünal Demet,ÖZEN ANIL,aydemir mustafa,Çalış Hasan,Boz Adil,Arıcı Cumhur Intraoperative Parathyroid Hormone Monitoring-Guided Subtotal Parathyroidectomy is an Effective and Valid Surgical Procedure for Secondary Hyperparathyroidism. Şişli Etfal Hastanesi Tıp Bülteni, vol.57, no.2, 2023, ss.272 - 278. 10.14744/SEMB.2023.48991
AMA GUZEL G,Sarıdemir Ünal D,ÖZEN A,aydemir m,Çalış H,Boz A,Arıcı C Intraoperative Parathyroid Hormone Monitoring-Guided Subtotal Parathyroidectomy is an Effective and Valid Surgical Procedure for Secondary Hyperparathyroidism. Şişli Etfal Hastanesi Tıp Bülteni. 2023; 57(2): 272 - 278. 10.14744/SEMB.2023.48991
Vancouver GUZEL G,Sarıdemir Ünal D,ÖZEN A,aydemir m,Çalış H,Boz A,Arıcı C Intraoperative Parathyroid Hormone Monitoring-Guided Subtotal Parathyroidectomy is an Effective and Valid Surgical Procedure for Secondary Hyperparathyroidism. Şişli Etfal Hastanesi Tıp Bülteni. 2023; 57(2): 272 - 278. 10.14744/SEMB.2023.48991
IEEE GUZEL G,Sarıdemir Ünal D,ÖZEN A,aydemir m,Çalış H,Boz A,Arıcı C "Intraoperative Parathyroid Hormone Monitoring-Guided Subtotal Parathyroidectomy is an Effective and Valid Surgical Procedure for Secondary Hyperparathyroidism." Şişli Etfal Hastanesi Tıp Bülteni, 57, ss.272 - 278, 2023. 10.14744/SEMB.2023.48991
ISNAD GUZEL, GOKMEN vd. "Intraoperative Parathyroid Hormone Monitoring-Guided Subtotal Parathyroidectomy is an Effective and Valid Surgical Procedure for Secondary Hyperparathyroidism". Şişli Etfal Hastanesi Tıp Bülteni 57/2 (2023), 272-278. https://doi.org/10.14744/SEMB.2023.48991